CORONA, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) announced today that their signature product,
the MedTainer, has been granted a Utility Patent from the Canadian Intellectual Property Office.
The Canadian patent allows Acology to move forward with their plan to become the primary packaging solution for the Canadian
recreational and medical cannabis market. Business has sharply increased over the past 60 days, as orders from Canadian LPs
(Licensed Producers) are up over 25%. It appears that this trend will continue for the foreseeable future.
The Canadian patent will also enable Acology to protect its product(s) from counterfeit or copy and will ensure that the LPs
will be able to offer their clients safe, compliant and customer-friendly packaging. Since Acology can also custom print and label
each MedTainer brand names will stay in front of the consumer longer. The MedTainer has a better than 98% customer approval
rating.
With the vote for legal recreational cannabis in Canada coming later this summer Acology will continue to aggressively position
its’ product(s) as the primary retail packaging source for what is expected to be more than 7 million consumers.
This news comes within 2 weeks of Acology’s purchase of the entire Intellectual Property Portfolio for the MedTainer, including
US design and utility patents, patents-pending in the EU, trademark(s), domain name(s) and all designs, molds, patterns and forms.
With the granting of the Canadian Utility Patent Acology has also substantially increased the net-value of its’ portfolio.
For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located
in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.
Acology trades on the OTC under the call letters ACOL. The company’s websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology
products can be taken online and by phone. Custom orders are especially welcome. Please send all inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649). Ask for Jack Rein, National Services
Director. Acology can also be accessed through Twitter and Instagram at @Acologyinc
This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such
statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond
could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as
“anticipates”, “projects”, “expects”, “planned”, “intends” and “believes” “estimate” “targets” and other similar expressions that
indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in
the loss of some or all of his or her investment.
